Lymphline Feature Phase 1 Independent Service Evaluation UK Treatment and Experiences of Head and Neck Lymphoedema (HNL)
PhysioPod® UK recently featured in the Spring 26 edition of the Lymphline newsletter, which is published by the Lymphoedema Support Network (LSN). The feature highlights PhysioPod’s recent national company-led scoping evaluation, titled "Phase 1 Analysis: UK Treatments and Experiences of Head and Neck Lymphoedema (HNL)". This initiative captures real-world data and feedback from both patients and healthcare professionals to shed light on the current treatment landscape, the challenges in managing head and neck lymphoedema, and how Deep Oscillation Therapy (DOT) can help bridge the gap in standard care.
